A novel and potent brain penetrant inhibitor of extracellular vesicle release-Reference-Cited by-同舟云学术

A novel and potent brain penetrant inhibitor of extracellular vesicle release

Published:2019-09-04 Issue:19 Volume:176 Page:3857-3870
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Rojas Camilo¹²^ORCID,Sala Michal³,Thomas Ajit G.¹,Datta Chaudhuri Amrita⁴,Yoo Seung‐Wan⁴,Li Zhigang⁴,Dash Ranjeet P.¹,Rais Rana¹⁴,Haughey Norman J.⁴,Nencka Radim³,Slusher Barbara¹⁴⁵⁶⁷

Affiliation:

1. Johns Hopkins Drug DiscoveryJohns Hopkins School of Medicine Baltimore Maryland

2. Department of Molecular and Comparative PathobiologyJohns Hopkins School of Medicine Baltimore Maryland

3. Chem Research GroupInstitute of Organic Chemistry and Biochemistry Prague Czech Republic

4. Department of NeurologyJohns Hopkins School of Medicine Baltimore Maryland

5. Department of Psychiatry and Behavioral SciencesJohns Hopkins School of Medicine Baltimore Maryland

6. Department of NeuroscienceJohns Hopkins School of Medicine Baltimore Maryland

7. Department of MedicineJohns Hopkins School of Medicine Baltimore Maryland

Funder

National Institutes of Health

European Regional Development Fund

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14789

Reference37 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

2. Depletion of microglia and inhibition of exosome synthesis halt tau propagation

3. Exosomes from uninfected cells activate transcription of latent HIV-1

4. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

5. TNFα and IL-1β modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aged fibroblast-derived extracellular vesicles promote angiogenesis in melanoma;Cell Reports;2024-09

2. Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia;Diabetes;2024-06-13

3. Fighting nature with nature: antiviral compounds that target retroviruses;Archives of Microbiology;2024-02-28

4. Development of novel tools for dissection of central versus peripheral dopamine D₂-like receptor signaling in dysglycemia;2024-02-23

5. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model;Translational Neurodegeneration;2023-12-04